CN109996870A - 从人多能干细胞产生中脑特异性类器官 - Google Patents

从人多能干细胞产生中脑特异性类器官 Download PDF

Info

Publication number
CN109996870A
CN109996870A CN201780029142.2A CN201780029142A CN109996870A CN 109996870 A CN109996870 A CN 109996870A CN 201780029142 A CN201780029142 A CN 201780029142A CN 109996870 A CN109996870 A CN 109996870A
Authority
CN
China
Prior art keywords
cell
percentage
replenishers
culture medium
organoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780029142.2A
Other languages
English (en)
Chinese (zh)
Inventor
曹重铉
黄学晖
诸炫秀
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agency for Science Technology and Research Singapore
National University of Singapore
Original Assignee
Agency for Science Technology and Research Singapore
National University of Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency for Science Technology and Research Singapore, National University of Singapore filed Critical Agency for Science Technology and Research Singapore
Publication of CN109996870A publication Critical patent/CN109996870A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0696Artificially induced pluripotent stem cells, e.g. iPS
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062General methods for three-dimensional culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0619Neurons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/119Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/13Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/15Transforming growth factor beta (TGF-β)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/33Insulin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40Regulators of development
    • C12N2501/41Hedgehog proteins; Cyclopamine (inhibitor)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40Regulators of development
    • C12N2501/415Wnt; Frizzeled
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70Enzymes
    • C12N2501/72Transferases (EC 2.)
    • C12N2501/727Kinases (EC 2.7.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999Small molecules not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/003D culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/50Proteins
    • C12N2533/54Collagen; Gelatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/50Proteins
    • C12N2533/56Fibrin; Thrombin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/70Polysaccharides
    • C12N2533/72Chitin, chitosan
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/70Polysaccharides
    • C12N2533/74Alginate
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/70Polysaccharides
    • C12N2533/76Agarose, agar-agar
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/70Polysaccharides
    • C12N2533/78Cellulose
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/90Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CN201780029142.2A 2016-03-14 2017-03-14 从人多能干细胞产生中脑特异性类器官 Pending CN109996870A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG10201601965P 2016-03-14
SG10201601965P 2016-03-14
PCT/SG2017/050126 WO2017160234A1 (fr) 2016-03-14 2017-03-14 Génération d'organoïdes spécifiques du mésencéphale à partir de cellules souches pluripotentes humaines

Publications (1)

Publication Number Publication Date
CN109996870A true CN109996870A (zh) 2019-07-09

Family

ID=59851957

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780029142.2A Pending CN109996870A (zh) 2016-03-14 2017-03-14 从人多能干细胞产生中脑特异性类器官

Country Status (5)

Country Link
US (1) US20190169576A1 (fr)
EP (1) EP3430132A4 (fr)
CN (1) CN109996870A (fr)
SG (2) SG10201913687VA (fr)
WO (1) WO2017160234A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113046309A (zh) * 2021-03-26 2021-06-29 成都云测医学生物技术有限公司 悬浮培养脑类器官的培养基及其应用
CN113249319A (zh) * 2021-05-19 2021-08-13 北京大学 一种脑脊液类器官的培养基及其培养方法
CN113493768A (zh) * 2021-09-06 2021-10-12 中国科学院动物研究所 神经类器官及其制备方法
CN113684182A (zh) * 2020-05-19 2021-11-23 武汉睿健医药科技有限公司 TGF-β抑制剂在诱导神经干细胞及类器官形成中的应用
CN113789301A (zh) * 2021-08-27 2021-12-14 广州瑞臻再生医学科技有限公司 一种制备高纯度的诱导性多能干细胞来源的人脑多巴胺能神经元的方法
CN114736864A (zh) * 2020-12-23 2022-07-12 武汉睿健医药科技有限公司 一种神经干细胞诱导分化培养基及诱导分化方法
CN115044539A (zh) * 2022-08-16 2022-09-13 中义(北京)健康研究院 一种鲨鱼肝细胞及其培养方法
CN115404218A (zh) * 2022-01-13 2022-11-29 南华大学附属第一医院 一种包含胶质细胞的3d人脑类器官培养方法

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011140441A2 (fr) 2010-05-06 2011-11-10 Children's Hospital Medical Center Procédés et systèmes de conversion de cellules précurseurs en tissus intestinaux par différenciation dirigée
EP3712254A1 (fr) 2014-05-28 2020-09-23 Children's Hospital Medical Center Procédés et systèmes de conversion de cellules précurseurs dans des tissus gastriques à travers la différenciation dirigée
US11584916B2 (en) 2014-10-17 2023-02-21 Children's Hospital Medical Center Method of making in vivo human small intestine organoids from pluripotent stem cells
EP4177335A1 (fr) 2016-05-05 2023-05-10 Children's Hospital Medical Center Procédés de fabrication in vitro de tissu de fundus d'estomac et compositions associées à celui-ci
US10583286B2 (en) * 2016-08-23 2020-03-10 Boston Scientific Neuromodulation Corporation Methods and devices for neuromodulation of the adrenal gland
SG10202105768WA (en) 2016-12-05 2021-06-29 Childrens Hospital Med Ct Colonic organoids and methods of making and using same
CN108456659B (zh) * 2018-03-14 2020-05-05 浙江霍德生物工程有限公司 3d大脑类器官的制备方法
CN110295145B (zh) * 2018-03-22 2020-10-16 苏州麦迪耐斯医药科技有限公司 一种体外培养脑肿瘤细胞的培养液及培养方法
JP2022500033A (ja) * 2018-09-11 2022-01-04 マックス−プランク−ゲゼルシャフト ツール フォーデルング デル ヴィッセンシャフテン エー.ヴェー. オルガノイドの自動化された生成および分析
US20220010271A1 (en) * 2018-11-15 2022-01-13 Jsr Corporation Method for producing brain organoids
JP2022519376A (ja) * 2019-02-11 2022-03-23 ミルテニイ ビオテック ベー.ファー. ウント コー.カーゲー 三次元マトリックスなしでのヒト多能性幹細胞由来人工組織構造体の生成
JP7366332B2 (ja) * 2019-06-05 2023-10-23 公立大学法人奈良県立医科大学 脳幹オルガノイドの作製方法
EP4001401A4 (fr) * 2019-07-05 2023-07-19 Keio University Procédé de fabrication d'organoïde cérébral
KR102228400B1 (ko) * 2019-09-24 2021-03-16 고려대학교 산학협력단 뇌 오가노이드 제조 방법
CN114729323A (zh) * 2019-11-22 2022-07-08 诺和诺德股份有限公司 旋转聚集的神经微球及其应用
EP4090734A1 (fr) * 2020-01-13 2022-11-23 Aspen Neuroscience, Inc. Procédé de différenciation de cellules nerveuses et compositions associées et méthodes d'utilisation
WO2021216622A1 (fr) * 2020-04-21 2021-10-28 Aspen Neuroscience, Inc. Édition génique de gba1 dans des cellules souches et procédé d'utilisation de cellules différenciées à partir de celles-ci
WO2021216623A1 (fr) * 2020-04-21 2021-10-28 Aspen Neuroscience, Inc. Édition génique de lrrk2 dans des cellules souches et procédé d'utilisation de cellules différenciées à partir de celles-ci
US20230323292A1 (en) * 2020-06-08 2023-10-12 Technische Universiteit Eindhoven Methods for producing a (three dimensional) neural tissue
WO2022005023A1 (fr) * 2020-06-29 2022-01-06 주식회사 오간팩토리 Organoïde de mésencéphale, son procédé de production rapide en grandes quantités, et procédé de criblage de neurotoxines et procédé de criblage de médicaments pour une maladie associée aux neurones dopaminergiques l'utilisant
KR102346243B1 (ko) * 2020-06-29 2022-01-04 주식회사 오간팩토리 중뇌 오가노이드, 이의 고속 및 대량 제조 방법, 이를 이용한 신경독성물질 스크리닝 방법 및 도파민성 신경세포 관련 질환 치료제 스크리닝 방법
EP3992280A1 (fr) * 2020-10-30 2022-05-04 Kugelmeiers Ltd. Procédé de génération de neurosphères
KR20230081737A (ko) * 2021-11-29 2023-06-08 주식회사 오간팩토리 간 오가노이드, 이의 고속 및 대량 제조 방법, 이를 이용한 약물의 효능 및 독성 스크리닝 방법
WO2023137200A2 (fr) * 2022-01-13 2023-07-20 The Board Of Trustees Of The Leland Stanford Junior University Génération d'organoïdes d'organisateur neuronal et d'assembloïdes de ligne médiane à partir de cellules souches pluripotentes humaines
WO2023201046A1 (fr) * 2022-04-14 2023-10-19 Lieber Institute, Inc. Compositions et méthode de traitement d'une dystonie-parkinsonisme liée à l'x
EP4286513A1 (fr) 2022-06-03 2023-12-06 IMBA-Institut für Molekulare Biotechnologie GmbH Fusion de culture de tissus triple
WO2024017538A1 (fr) * 2022-07-19 2024-01-25 Medizinische Hochschule Hannover Procédé de production d'organoïdes à partir de cellules de mammifère
EP4310177A1 (fr) * 2022-07-19 2024-01-24 Medizinische Hochschule Hannover Procédé de production d'organoïdes à partir de cellules de mammifères
WO2024113351A1 (fr) * 2022-12-02 2024-06-06 Nuwacell Biotechnologies Co., Ltd. Milieu de culture, matrice de revêtement et procédé de maturation de cellules progénitrices dopaminergiques du mésencéphale
CN117778313B (zh) * 2024-02-23 2024-05-24 成都云测医学生物技术有限公司 脑类器官获得间充质干细胞分化方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104024401A (zh) * 2011-06-10 2014-09-03 荷兰皇家科学院 用于干细胞的培养基
WO2015135893A1 (fr) * 2014-03-11 2015-09-17 NeuroProof GmbH Obtention de cultures neuronales spécifiques à une région cérébrale à partir de cultures tissulaires tridimensionnelles de cellules souches
US20150330970A1 (en) * 2012-12-13 2015-11-19 Imba - Institut Fur Molekulare Biotechnologie Gmbh Three dimensional heterogeneously differentiated tissue culture

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2014147015A (ru) * 2012-04-24 2016-06-10 Интернэшнл Стем Селл Корпорейшн Получение нервных стволовых клеток и дофаминергических нейронов из плюрипотентных стволовых клеток человека
KR101696874B1 (ko) * 2013-07-31 2017-01-16 한국생명공학연구원 직접 리프로그래밍을 통한 유도 도파민성 전구세포 제조방법
EP3119881B1 (fr) * 2014-03-21 2023-03-01 FUJIFILM Cellular Dynamics, Inc. Derivation de neurones dopaminergiques du mesencephale
US11214768B2 (en) * 2015-03-03 2022-01-04 President And Fellows Of Harvard College Methods of generating functional human tissue
LU92845B1 (en) * 2015-10-08 2017-05-02 Univ Du Luxembourg Campus Belval Means and methods for generating midbrain organoids
EP3190176A1 (fr) * 2016-01-11 2017-07-12 IMBA-Institut für Molekulare Biotechnologie GmbH Procédé de développement de culture tissulaire sur échafaudage et culture de tissus différenciés

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104024401A (zh) * 2011-06-10 2014-09-03 荷兰皇家科学院 用于干细胞的培养基
US20150330970A1 (en) * 2012-12-13 2015-11-19 Imba - Institut Fur Molekulare Biotechnologie Gmbh Three dimensional heterogeneously differentiated tissue culture
WO2015135893A1 (fr) * 2014-03-11 2015-09-17 NeuroProof GmbH Obtention de cultures neuronales spécifiques à une région cérébrale à partir de cultures tissulaires tridimensionnelles de cellules souches

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
JUNGHYUN JO等: "Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons", 《CELL STEM CELL》, vol. 19, 28 July 2016 (2016-07-28), XP029675877, DOI: 10.1016/j.stem.2016.07.005 *
VANNARY TIENG等: "Engineering of midbrain organoids containing long-lived dopaminergic neurons", 《STEM CELLS AND DEVELOPMENT》 *
VANNARY TIENG等: "Engineering of midbrain organoids containing long-lived dopaminergic neurons", 《STEM CELLS AND DEVELOPMENT》, vol. 23, no. 13, 27 February 2014 (2014-02-27), pages 1536 *
杨雄雄: "类大脑的作用和伦理问题", 《百科知识》 *
杨雄雄: "类大脑的作用和伦理问题", 《百科知识》, vol. 19, 1 October 2015 (2015-10-01) *
樊晓明等: "《中国疾病信号通路与靶向治疗学》", 安徽科学技术出版社, pages: 5 - 19 *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113684182A (zh) * 2020-05-19 2021-11-23 武汉睿健医药科技有限公司 TGF-β抑制剂在诱导神经干细胞及类器官形成中的应用
WO2021232830A1 (fr) * 2020-05-19 2021-11-25 武汉睿健医药科技有限公司 Application de l'inhibiteur de tgf-β dans l'induction de cellules souches neurales et la formation d'organoïdes
CN113684182B (zh) * 2020-05-19 2023-12-22 武汉睿健医药科技有限公司 TGF-β抑制剂在诱导神经干细胞及类器官形成中的应用
CN114736864B (zh) * 2020-12-23 2024-01-26 武汉睿健医药科技有限公司 一种神经干细胞诱导分化培养基及诱导分化方法
CN114736864A (zh) * 2020-12-23 2022-07-12 武汉睿健医药科技有限公司 一种神经干细胞诱导分化培养基及诱导分化方法
CN113046309B (zh) * 2021-03-26 2023-05-05 成都云测医学生物技术有限公司 悬浮培养脑类器官的培养基及其应用
CN113046309A (zh) * 2021-03-26 2021-06-29 成都云测医学生物技术有限公司 悬浮培养脑类器官的培养基及其应用
CN113249319A (zh) * 2021-05-19 2021-08-13 北京大学 一种脑脊液类器官的培养基及其培养方法
CN113249319B (zh) * 2021-05-19 2022-11-11 北京大学 一种脑脊液类器官的培养基及其培养方法
CN113789301A (zh) * 2021-08-27 2021-12-14 广州瑞臻再生医学科技有限公司 一种制备高纯度的诱导性多能干细胞来源的人脑多巴胺能神经元的方法
CN113789301B (zh) * 2021-08-27 2022-05-10 广州瑞臻再生医学科技有限公司 一种制备高纯度的诱导性多能干细胞来源的人脑多巴胺能神经元的方法
CN113493768B (zh) * 2021-09-06 2021-12-24 中国科学院动物研究所 神经类器官及其制备方法
CN113493768A (zh) * 2021-09-06 2021-10-12 中国科学院动物研究所 神经类器官及其制备方法
CN115404218A (zh) * 2022-01-13 2022-11-29 南华大学附属第一医院 一种包含胶质细胞的3d人脑类器官培养方法
CN115044539A (zh) * 2022-08-16 2022-09-13 中义(北京)健康研究院 一种鲨鱼肝细胞及其培养方法

Also Published As

Publication number Publication date
SG11201807487WA (en) 2018-09-27
EP3430132A1 (fr) 2019-01-23
WO2017160234A1 (fr) 2017-09-21
SG10201913687VA (en) 2020-03-30
US20190169576A1 (en) 2019-06-06
EP3430132A4 (fr) 2019-12-25

Similar Documents

Publication Publication Date Title
CN109996870A (zh) 从人多能干细胞产生中脑特异性类器官
JP7023820B2 (ja) 多分化能細胞および多能性細胞の分化を方向付けることによって発生させる皮質介在ニューロンおよびその他のニューロン細胞
Cho et al. Microfluidic device with brain extracellular matrix promotes structural and functional maturation of human brain organoids
Koehler et al. Generation of inner ear organoids containing functional hair cells from human pluripotent stem cells
Xu et al. Construction of a mammalian embryo model from stem cells organized by a morphogen signalling centre
Koehler et al. 3D mouse embryonic stem cell culture for generating inner ear organoids
CN107438669B (zh) 用于治疗神经退行性疾病的干细胞衍生多巴胺能细胞的生产方法和组合物
CN104379732B (zh) 由人多能干细胞衍生神经干细胞和多巴胺能神经元
Adil et al. Efficient generation of hPSC-derived midbrain dopaminergic neurons in a fully defined, scalable, 3D biomaterial platform
Germain et al. Derivation and isolation of NKX2. 1-positive basal forebrain progenitors from human embryonic stem cells
CN105940101A (zh) 由人多能干细胞特化功能性颅基板衍生物
CN109844102A (zh) 分化多能细胞的方法
CN106795494A (zh) 从干细胞分化为视网膜神经节细胞的方法
CN108699528A (zh) 在先天性巨结肠症中通过衍生自多能干细胞的人肠神经嵴谱系可行的基于细胞的治疗和药物开发
CN105658788A (zh) 多巴胺能神经元的制备方法
CN109072198A (zh) 产多巴胺神经祖细胞的制备方法
Guy et al. Human neural organoids: Models for developmental neurobiology and disease
Gopalakrishnan The emergence of stem cell‐based brain organoids: trends and challenges
TW202024323A (zh) 含有嗅神經細胞或其前驅細胞之細胞塊及其製造方法
US20220202872A1 (en) Method for generating a three-dimensional neuromuscular organoid in vitro
US20210284962A1 (en) Generation of a population of hindbrain cells and hindbrain-like organoids from pluripotent stem cells
Gribaudo et al. Self-organizing models of human trunk organogenesis recapitulate spinal cord and spine co-morphogenesis
Mukherjee et al. Making NSC and neurons from patient-derived tissue samples
Saeki et al. Critical roles of FGF, RA, and WNT signalling in the development of the human otic placode and subsequent lineages in a dish
Phillips et al. Developing HiPSC derived serum free embryoid bodies for the interrogation of 3-D stem cell cultures using physiologically relevant assays

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination